z-logo
open-access-imgOpen Access
No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease
Author(s) -
Kelly A. Dougherty,
Joan I. Schall,
Deborah A. Kawchak,
Michael H. Green,
Kwaku OheneFrempong,
Babette S. Zemel,
Virginia A. Stallings
Publication year - 2012
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.112.035725
Subject(s) - placebo , medicine , vitamin , retinol , retinyl palmitate , vitamin a deficiency , population , vitamin d and neurology , endocrinology , gastroenterology , pathology , environmental health , alternative medicine
Suboptimal vitamin A status is prevalent in children with type SS sickle cell disease (SCD-SS) and is associated with hospitalizations and poor growth and hematologic status. The supplemental vitamin A dose that optimizes suboptimal vitamin A status in this population is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom